XML 46 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Mar. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Assumptions were used in the Fair-Value Method The weighted-average grant date fair values of stock options granted during the years ended March 31, 2024 and 2023 was $0.99 and $2.85, respectively. The following assumptions were used in the fair-value method calculations:
      Year Ended March 31,  
      2024       2023  
Risk-free interest rates     3.51% - 4.72%       2.82% - 4.06%  
Volatility     83% - 152%       83% - 223%  
Expected life (years)     5.0 - 6.2       5.0 – 5.7  
Dividend yield     —       —  
Schedule of Summarizes the Activity in the Shares The following table summarizes the activity in the shares available for grant under the Plan during the year ended March 31, 2024:
       Options Outstanding 
  

Shares

Available

for Grant

   Number of
Shares		   Weighted
Average
Exercise
Price		 
Balance at March 31, 2022   989,466    1,650,705   $6.58 
Additional shares authorized under the Plan   2,000,000    —    — 
Options granted   (1,006,074)   1,006,074    3.15 
Share awards   (26,789)   —    — 
Options cancelled and returned to the Plan   175,689    (175,689)   6.48 
Balance at March 31, 2023   2,132,292    2,481,090    5.19 
Additional shares authorized under the Plan   3,000,000    —    — 
Options granted   (1,448,533)   1,448,533    0.99 
Share awards   (25,390)   —    — 
RSUs granted   (250,000)   —    — 
Options cancelled and returned to the Plan   240,282    (240,282)   3.84 
Balance at March 31, 2024   3,648,651    3,689,341   $3.70 
Schedule of RSU Activity under the Plan A summary of RSU activity under the Plan is presented below.
  

Number of

Shares

  

Weighted

Average

Grant-

Date

Fair Value

 
Balance at March 31, 2023   
—
    
—
 
Granted   250,000   $0.91 
Vested   (62,501)   0.91 
Balance at March 31, 2024  $187,499   $0.91 
Schedule of Outstanding and Exercisable Options The following table summarizes the range of outstanding and exercisable options as of March 31, 2024:
   Options Outstanding   Options Exercisable 
       Weighted                 
       Average                 
       Remaining   Weighted       Weighted     
       Contractual   Average       Average   Aggregate 
   Number   Life   Exercise   Number   Exercise   Intrinsic 
Range of Exercise Price  Outstanding   (in Years)   Price   Exercisable   Price   Value 
$0.93 - $2.00   2,237,066    8.31   $1.48    1,409,750   $1.52   $538,006 
$3.95 - $7.51   943,145    7.20    5.29    771,478    5.52    — 
$8.61 - $17.70   509,130    7.23    10.53    470,442    10.53    — 
$0.93 - $17.70   3,689,341    7.88   $3.70    2,651,670   $4.28   $538,006